140 related articles for article (PubMed ID: 19091833)
1. Does antidepressant medication in patients with hepatitis C undergoing interferon alpha treatment reduce therapeutic efficacy?
Robaeys G; Wichers MC; De Bie J; Koek GH; Buntinx F; Van Os J
Gut; 2009 Jan; 58(1):145; author reply 145-6. PubMed ID: 19091833
[No Abstract] [Full Text] [Related]
2. Serotonin-norepinephrine reuptake inhibitor desvenlafaxine for the treatment of interferon alfa-associated depression in patients with hepatitis C.
Fábregas B; Moura A; Ávila R; Carmo R; Teixeira AL
Braz J Psychiatry; 2014; 36(2):183. PubMed ID: 24839091
[No Abstract] [Full Text] [Related]
3. Norepinephrine-enhancing antidepressant exposure associated with reduced antiviral effect of interferon alpha on hepatitis C.
Fialho R; Burridge A; Pereira M; Keller M; File A; Tibble J; Whale R
Psychopharmacology (Berl); 2016 May; 233(9):1689-94. PubMed ID: 25971875
[TBL] [Abstract][Full Text] [Related]
4. Novel treatment strategies for depression in patients with hepatitis C.
Loftis JM; Turner EH
Psychosomatics; 2010; 51(4):357-8. PubMed ID: 20587769
[No Abstract] [Full Text] [Related]
5. Escitalopram for the prevention of peginterferon-α2a-associated depression.
Schaefer M; Berg T; Sarkar S; Neumann K
Ann Intern Med; 2013 Jan; 158(2):140. PubMed ID: 23318324
[No Abstract] [Full Text] [Related]
6. Escitalopram for the prevention of peginterferon-α2a-associated depression.
Landman GW
Ann Intern Med; 2013 Jan; 158(2):139-40. PubMed ID: 23318323
[No Abstract] [Full Text] [Related]
7. Summaries for Patients. Prevention of depression in patients treated for chronic hepatitis C virus infection with interferon-alpha.
Ann Intern Med; 2012 Jul; 157(2):I-40. PubMed ID: 22801693
[No Abstract] [Full Text] [Related]
8. Bupropion for treatment of interferon-induced depression.
Malek-Ahmadi P; Ghandour E
Ann Pharmacother; 2004; 38(7-8):1202-5. PubMed ID: 15150377
[TBL] [Abstract][Full Text] [Related]
9. Platelet serotonin (5-HT) levels in interferon-treated patients with hepatitis C and its possible association with interferon-induced depression.
Schäfer A; Scheurlen M; Seufert J; Keicher C; Weissbrich B; Rieger P; Kraus MR
J Hepatol; 2010 Jan; 52(1):10-5. PubMed ID: 19897271
[TBL] [Abstract][Full Text] [Related]
10. Antidepressant pretreatment for the prevention of interferon alfa-associated depression: a systematic review and meta-analysis.
Sarkar S; Schaefer M
Psychosomatics; 2014; 55(3):221-34. PubMed ID: 24012293
[TBL] [Abstract][Full Text] [Related]
11. Treatment considerations for the client with interferon-alpha-induced depression.
Antai-Otong D
Perspect Psychiatr Care; 2003; 39(4):174-5. PubMed ID: 14737824
[No Abstract] [Full Text] [Related]
12. Paroxetine for the prevention of depression induced by interferon alfa.
Kraus MR; Schäfer A; Scheurlen M
N Engl J Med; 2001 Aug; 345(5):375-6. PubMed ID: 11484704
[No Abstract] [Full Text] [Related]
13. Therapy of interferon-induced depression in chronic hepatitis C with citalopram: a randomised, double-blind, placebo-controlled study.
Kraus MR; Schäfer A; Schöttker K; Keicher C; Weissbrich B; Hofbauer I; Scheurlen M
Gut; 2008 Apr; 57(4):531-6. PubMed ID: 18079286
[TBL] [Abstract][Full Text] [Related]
14. Prophylactic SSRI during interferon alpha re-therapy in patients with chronic hepatitis C and a history of interferon-induced depression.
Kraus MR; Schäfer A; Al-Taie O; Scheurlen M
J Viral Hepat; 2005 Jan; 12(1):96-100. PubMed ID: 15655055
[TBL] [Abstract][Full Text] [Related]
15. Psychiatric clearance for patients started on interferon-alpha-based therapies.
Lotrich FE
Am J Psychiatry; 2013 Jun; 170(6):592-7. PubMed ID: 23732965
[No Abstract] [Full Text] [Related]
16. Paroxetine for the treatment of interferon-alpha-induced depression in chronic hepatitis C.
Kraus MR; Schäfer A; Faller H; Csef H; Scheurlen M
Aliment Pharmacol Ther; 2002 Jun; 16(6):1091-9. PubMed ID: 12030950
[TBL] [Abstract][Full Text] [Related]
17. Safety of the treatment of interferon-alpha-induced depression.
Loftis JM; Hauser P
Psychosomatics; 2003; 44(6):524-6. PubMed ID: 14597693
[No Abstract] [Full Text] [Related]
18. Prevention of interferon-alpha-associated depression with antidepressant medications in patients with hepatitis C virus: a systematic review and meta-analysis.
Ehret M; Sobieraj DM
Int J Clin Pract; 2014 Feb; 68(2):255-61. PubMed ID: 24372654
[TBL] [Abstract][Full Text] [Related]
19. [Escitalopram for intervention of psychiatric adverse events during peginterferon-alfa-2a and ribavirin treatment for chronic hepatitis C].
Qi M; Zhou B; Su M; Pan J; Zhang H
Nan Fang Yi Ke Da Xue Xue Bao; 2013 Jul; 33(7):1012-6. PubMed ID: 23895843
[TBL] [Abstract][Full Text] [Related]
20. Escitalopram for the prevention of peginterferon-α2a-associated depression in hepatitis C virus-infected patients without previous psychiatric disease: a randomized trial.
Schaefer M; Sarkar R; Knop V; Effenberger S; Friebe A; Heinze L; Spengler U; Schlaepfer T; Reimer J; Buggisch P; Ockenga J; Link R; Rentrop M; Weidenbach H; Fromm G; Lieb K; Baumert TF; Heinz A; Discher T; Neumann K; Zeuzem S; Berg T
Ann Intern Med; 2012 Jul; 157(2):94-103. PubMed ID: 22801672
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
